<DOC>
	<DOCNO>NCT00539123</DOCNO>
	<brief_summary>A randomized clinical trial evaluate whether Behavioral Drug HIV Risk Reduction Counseling ( BDRC ) , abstinence-contingent take-home buprenorphine ( ACB ) , combination two improve efficacy cost-effectiveness standard buprenorphine treatment opiate-dependent individual Malaysia .</brief_summary>
	<brief_title>Drug Counseling Abstinent-Contingent Take-Home Buprenorphine Malaysia</brief_title>
	<detailed_description>Heroin injection drug use ( IDU ) highly prevalent drive HIV epidemic Malaysia country region . In original RCT , buprenorphine ( BUP ) superior naltrexone placebo treatment retention , week consecutive abstinence time heroin use . However , room improvement , since 50 % subject assign BUP remain treatment 6 month ; 28 % avoid relapse heroin ; BUP reduce drug- sex-related HIV risk behavior . In actual clinical practice Malaysia U.S. , Standard BUP provide relatively minimal psychosocial service ( brief physician management ( PM ) weekly less frequent medication pick-up ) may even less effective . Hence , propose follow study evaluate whether Standard BUP sufficient whether one combination two enhance behavioral treatment -- behavioral drug HIV risk reduction counseling ( BDRC ) abstinence-contingent take-home buprenorphine ( ACB ) â€”improve efficacy cost-effective , regard direct economic cost provide treatment . BDRC utilizes short-term behavioral contract promote abstinence reduce drug- sex-related HIV risk behavior provide nurse medical assistant available medical setting Malaysia . ACB , low cost feasible alternative non-contingent take-home buprenorphine , retain many advantage -- abstinent patient manage medication supply outside clinic -- ACB also provide positive incentive abstinence directly observe buprenorphine continue heroin use . In proposed 2X2 study , heroin dependent patient ( N=240 ) induct onto buprenorphine ( week 1-2 ) randomize Standard BUP , Standard BUP ACB , Standard BUP BDRC , Standard BUP ( week 3-26 ) . Primary outcome measure include reduction heroin use ( percent day abstinent , proportion opiate-negative urine test , maximum consecutive week abstinent ) reductions drug- sex-related HIV risk behavior . Secondary outcome include retention ; reduction drug use , hospitalization , criminal behavior arrest ; improvement vocational family functioning . Data analyse focus intention-to treat sample . The study result inform practice guideline policy regard buprenorphine treatment .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>opioid dependence current dependence alcohol , benzodiazepines sedative current suicide homicide risk current psychotic disorder major depression inability understand protocol assessment question life threaten unstable medical problem 3x normal liver enzyme</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>buprenorphine</keyword>
	<keyword>drug counseling</keyword>
	<keyword>HIV risk reduction counsel</keyword>
</DOC>